5-[(2-chlorophenyl)sulfanyl]-6'-[(3,4-difluorophenyl)amino]-4-hydroxy-2-(6-phenoxypyridin-2-yl)-1,2,3,6-tetrahydro-[2,2'-bipyridin]-6-one

ID: ALA5194549

Chembl Id: CHEMBL5194549

PubChem CID: 168285831

Max Phase: Preclinical

Molecular Formula: C33H23ClF2N4O3S

Molecular Weight: 629.09

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(c2cccc(Nc3ccc(F)c(F)c3)n2)(c2cccc(Oc3ccccc3)n2)CC(O)=C1Sc1ccccc1Cl

Standard InChI:  InChI=1S/C33H23ClF2N4O3S/c34-22-10-4-5-11-26(22)44-31-25(41)19-33(40-32(31)42,28-13-7-15-30(39-28)43-21-8-2-1-3-9-21)27-12-6-14-29(38-27)37-20-16-17-23(35)24(36)18-20/h1-18,41H,19H2,(H,37,38)(H,40,42)

Standard InChI Key:  VFTRNEGLUGPGEU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5194549

    ---

Associated Targets(Human)

LDHA Tchem L-lactate dehydrogenase A chain (1573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LDHB Tchem L-lactate dehydrogenase B chain (463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 629.09Molecular Weight (Monoisotopic): 628.1147AlogP: 8.27#Rotatable Bonds: 8
Polar Surface Area: 96.37Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 5.65CX Basic pKa: 4.14CX LogP: 7.22CX LogD: 5.60
Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.16Np Likeness Score: -1.20

References

1. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]
2. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]

Source